Moxetumomab pasudotox-tdfk Intravenous and Ulipristal Acetate
Determining the interaction of Moxetumomab pasudotox-tdfk Intravenous and Ulipristal Acetate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: ulipristal
Brand name: Ella, Ella
Synonyms: Ulipristal
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-tdfk Intravenous-Ulipristal Tablets (Ella)
- Moxetumomab pasudotox-tdfk Intravenous-Uloric
- Moxetumomab pasudotox-tdfk Intravenous-Ultacan
- Moxetumomab pasudotox-tdfk Intravenous-Ultane
- Moxetumomab pasudotox-tdfk Intravenous-Ultane Amerinet
- Moxetumomab pasudotox-tdfk Intravenous-Ultane Novation
- Ulipristal Acetate-Moxifloxacin
- Ulipristal Acetate-Moxifloxacin (Systemic)
- Ulipristal Acetate-Moxifloxacin Hydrochloride
- Ulipristal Acetate-Moxifloxacin Injection
- Ulipristal Acetate-Moxifloxacin Intravenous
- Ulipristal Acetate-Moxifloxacin Tablets